World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

EVOLUTION OF ANAEMIA IN PULMONARY TUBERCULOSIS PATIENTS ON ANTI-TUBERCULOSIS THERAPY

Williams Bitty Azachi*, Kanayo Eugene Ikeh and Bello Bashir

ABSTRACT

Anaemia of chronic disease (ACD) is a form of anaemia seen in chronic illnesses such as in active pulmonary tuberculosis (TB) patients. In such cases, iron is sequestered in macrophages limiting availability to invading organisms in a bid to control the infection. Our research bordered on finding out if the anaemia will be resolved as tuberculosis treatment proceeds, without need for iron-rich supplements. We recruited 110 active pulmonary tuberculosis patients and 110 age- and gender-matched apparently healthy controls to this study and compared their haemoglobin concentration values. The tuberculosis patients were further grouped into 3: Group 1 comprising of newly diagnosed patients before start of treatment; Group 2 comprised of TB patients 2 months after start of treatment, and Group 3 had patients 6 months after start of treatment. The haemoglobin concentration of patients in each group were compared to the controls. This study found a significantly lower haemoglobin concentration in TB patients across all age groups and gender when compared to the controls (P-value

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR